Journal of ultrasound · 2026
Ultrasound-guided percutaneous cholecystostomy for acute cholecystitis: a systematic review and meta-analysis.
СтатьяСистематический обзорМетаанализНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Boccatonda Andrea, Brighenti Alice, Musmeci Marco, Venturoli Nicola, Masi Livia, Agostinelli Daniela, Bakken Sofia Maria, Vicari Susanna, Schiavone Cosima, Serra Carla
Аннотация
BACKGROUND: Ultrasound-guided percutaneous cholecystostomy (US-PC) is widely used in high-risk surgical patients with acute cholecystitis. Still, success and safety rates specific to US guidance are not always distinguished within mixed 'image-guided' series.
OBJECTIVE: To estimate technical success, clinical success, and major complication rates of US-PC.
METHODS: Primary studies explicitly reporting US-PC or with separable data were included.
PRIMARY OUTCOMES: technical success, clinical success (as defined by the study), and major adverse events (AEs). Single-arm meta-analysis using random-effects (logit, continuity correction); heterogeneity by I2 and prediction interval.
RESULTS: Four eligible single-arm studies for technical success (N = 466). Pooled technical success 99.3% (95%CI 97.8-99.8; I2 = 0%). Three studies (N = 223) reported clinical success: pooled 97.6% (95%CI 83.4-99.7; I2≈64% due to varying definitions). Two studies (N = 293) reported major AEs: pooled 1.7% (95%CI 0.7-4.1; I2 = 0%). Thirty-day mortality is available from one large study (6.2%).
CONCLUSIONS: In high-risk patients, US-PC demonstrates very high technical success and low major complication rates; clinical success is high but variably defined across studies. Further direct comparisons and standardized definitions are warranted.
OBJECTIVE: To estimate technical success, clinical success, and major complication rates of US-PC.
METHODS: Primary studies explicitly reporting US-PC or with separable data were included.
PRIMARY OUTCOMES: technical success, clinical success (as defined by the study), and major adverse events (AEs). Single-arm meta-analysis using random-effects (logit, continuity correction); heterogeneity by I2 and prediction interval.
RESULTS: Four eligible single-arm studies for technical success (N = 466). Pooled technical success 99.3% (95%CI 97.8-99.8; I2 = 0%). Three studies (N = 223) reported clinical success: pooled 97.6% (95%CI 83.4-99.7; I2≈64% due to varying definitions). Two studies (N = 293) reported major AEs: pooled 1.7% (95%CI 0.7-4.1; I2 = 0%). Thirty-day mortality is available from one large study (6.2%).
CONCLUSIONS: In high-risk patients, US-PC demonstrates very high technical success and low major complication rates; clinical success is high but variably defined across studies. Further direct comparisons and standardized definitions are warranted.